Burden Disease of Aortic Stenosis Associated in Patients Undergoing Transcatheter Aortic Valve Replacement

OBJECTIVES: To estimate the cost and length of stay (LOS) of aortic stenosis {AS) with transcatheter aortic valve replacement (TAVR) METHODS: An administrative claims database containing over 18 million lives (ORIZON, Brazilian Private Health Care, Fee-for-service) was assessed (from jan/2015 until dec/2016), of patients who underwent a transcatheter aortic valve replacement (n=84). Records showed expenditure with material, tax, procedures, medication and diagnostics. The average and median with confidence interval of 95% was adopted. RESULTS: 84 patients made use of TAV1 and had complete index hospital bills available (the treatment in Brazil are approval only for inoperable and high-risk patients) .The averange cost per patient was BRL 231,972 (include the valve and complications), the cost per day was BRL 9,896 (IC95% 5,579 -14,213), and the median LOS was 16 days. Almost 55% of cost was related with other expenses (tax, procedure, others materials and medications. CONCLUSIONS: Most of the treatment cost were not related with Device for this reason the avoidance clinical complications should improve the LOS and cost treatment of TAVR for high-risk and inoperable patients.